Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000685852 | SCV000813351 | likely pathogenic | Multiple congenital exostosis | 2018-06-23 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine with serine at codon 191 of the EXT1 protein (p.Leu191Ser). The leucine residue is moderately conserved and there is a large physicochemical difference between leucine and serine. This variant is not present in population databases (ExAC no frequency). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has been observed to segregate with hereditary multiple exotoses in a family (Invitae) and has been reported in an additional, unrelated affected individual (PMID: 17041877). |